Trials / Completed
CompletedNCT02131051
Application of Ectoine Containing Nasal Spray and Eye Drops in Patients With Allergic Rhinitis
Non-interventional Study: Application of Ectoin® Rhinitis Nasal Spray and Eye Drops in Patients With Allergic Rhinitis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 48 (actual)
- Sponsor
- Bitop AG · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This is a comparative, open label, parallel group, non interventional study to further demonstrate the effectiveness and tolerability of Ectoin Allergy Nasal Spray and Eye drops. In addition the effectiveness and safety shall be compared to Azelastine containing nasal Sprays and Eye drops. The patient applied Ectoin® Rhinitis Nasal Spray / Eye drops or takes Azelastine nasals spray and eye drops according to the instructions for use. The observation takes place over a period of 7 days. Response to treatment is recorded at day 7 by the physician and in daily by the patient in a dairy.
Conditions
Timeline
- Start date
- 2010-06-01
- Primary completion
- 2010-09-01
- Completion
- 2010-09-01
- First posted
- 2014-05-06
- Last updated
- 2014-05-06
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02131051. Inclusion in this directory is not an endorsement.